Not Tagged
Not Tagged
['biomarker']
 agree, ongoing efforts are important. biomarkers, tme, immunology, all important. but the prospective data that exists do not support the use of nac for r-pdac. there are also many treatments that we think make sense but don t pan out in phase 3 trials. time will tell.
HPB surgical oncologist w/focus on colorectal liver metastases. @VUMCSurgRes & @sloan_kettering alum. Former musician. Cameron Crazy. Tweets are my own.